BDP/FF NEXThaler将在现实世界中改善喘控制状态:纽顿研究
Fulvio Braido1,2, Enrico Arnaboldi1,2, Sara Barile3
1Respiratory Unit for Continuity of Care, IRCCS, Ospedale Policlinico San Martino, Genova, Italy.
Journal of asthma and allergy
|October 31, 2023
概括
纽顿研究将评估在中度至重度喘患者中,额外精细贝克洛美塔二二/格尔醇烟酸二水合物 (BDP/FF) 维护和缓解疗法 (MART) 的现实有效性. 它的目的是通过患者报告的结果来确定喘控制和生活质量的改善.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学 是一个学科.
- 现实世界的证据研究研究.
背景情况:
- 喘管理依赖于有效的吸入器疗法.
- 使用额外精细配方的维护和缓解疗法 (MART) 提供了一个潜在的治疗策略.
- 现实世界数据 (RWD) 对于了解常规临床实践中的治疗有效性至关重要.
研究的目的:
- 通过干粉吸入器 (DPI) 在中度至重度喘患者中评估额外精细贝克洛美塔二 propionate/formoterol fumarate二水合 (BDP/FF) 的实际使用和有效性.
- 评估使用MART实现改善喘控制的患者比例.
- 评估患者报告的结果,包括喘控制,生活质量和治疗坚持.
主要方法:
- 前性,多国,多中心,观察性研究设计.
- 使用数字收集的患者报告结果 (PRO):5项喘控制问卷,EuroQol5维5级,吸入器坚持性测试.
- 在一个小组中验证了一种新型的PRO,即"健康感变化速度"问卷.
主要成果:
- 该研究旨在收集患者感知到的临床益处的数据.
- 主要结局:改善喘控制的患者比例.
- 二次结果:评估生活质量和治疗坚持.
结论:
- 纽顿研究将提供现实世界的洞察力,了解BDP/FF MART在中度至重度喘中的有效性.
- 结果将反映出根据当前临床实践治疗的大型欧洲队列的结果.
- 这项研究将为RWD提供有价值的贡献,以告知喘治疗策略.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Antiasthma Drugs: β2-Adrenoceptor Agonists
278
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
278
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Heart Failure Drugs: β-Blockers
346
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
346
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K


